Dear Editor, We read with great interest the study by Zhou et al, which compared the predictive value of four nutritional assessment tools for postoperative acute kidney injury (AKI) across derivation and validation cohorts1. The authors should be commended for their rigorous validation process, demonstrating that simple serum albumin consistently outperformed complex composite indices (PNI, GNRI, CONUT), particularly in diabetic patients. This finding challenges the prevailing trend of creating increasingly complex scoring systems and reaffirms the value of fundamental biomarkers. However, to translate these findings into precise perioperative management, several physiological dimensions warrant deeper scrutiny. This letter adheres to the TITAN guidelines2. First, the “Inflammation-Malnutrition” interaction requires careful disentanglement. The study identifies hypoalbuminemia as a premier predictor. However, albumin is a negative acute-phase reactant; its synthesis is suppressed by cytokines (e.g., IL-6, TNF-α) during chronic inflammatory states (such as cancer or cardiovascular disease), independent of nutritional intake3. Consequently, a low preoperative albumin may reflect a high inflammatory burden rather than simple protein-energy malnutrition. To enhance specificity, future predictive models should ideally integrate the “C-reactive Protein/Albumin Ratio”. This adjustment would allow clinicians to discern whether the AKI risk is driven by nutritional substrate deficiency (requiring nutritional support) or inflammatory priming (requiring anti-inflammatory or immunomodulatory strategies). Second, the reliance on a single preoperative “snapshot” may overlook the dynamic hemodynamic stress of surgery. Major surgery induces rapid capillary leak and fluid shifts, leading to acute dilutional hypoalbuminemia4. We propose that the dynamic trajectory of albumin – specifically the “Delta Albumin” (the percentage drop from preoperative to immediate postoperative levels) – might serve as a superior “stress test” for renal susceptibility. A precipitous drop in albumin reflects not just nutritional status but the integrity of the endothelial glycocalyx and vascular permeability. Patients with a steep “Delta” likely experience more severe renal hypoperfusion and interstitial edema, mechanisms central to AKI pathogenesis. Shifting from static prediction to dynamic monitoring could offer an earlier window for intervention. Third, biochemical markers should not exist in isolation from “Functional Phenotypes.” While serum albumin reflects visceral protein reserves, it correlates poorly with skeletal muscle mass in the era of the obesity epidemic. “Sarcopenic obesity” – high adiposity with low muscle mass – is a silent killer often missed by body mass index and serum markers but strongly linked to adverse surgical outcomes5. Integrating morphological assessments, such as Psoas Muscle Area derived from routine preoperative CT scans, with serum albumin would create a “Bio-Morphological” risk stratification system. This dual approach would capture patients who are biochemically stable but physiologically frail, a subgroup at high risk for AKI due to limited metabolic reserve. In conclusion, Zhou et al provide compelling evidence for the utility of albumin in AKI prediction. Moving forward, calibrating albumin against inflammation, tracking its perioperative trajectory, and complementing it with functional muscle assessment will be pivotal in evolving from “risk prediction” to “targeted prevention.”
Peng et al. (Fri,) studied this question.